The Challenge of Type 1 Diabetes Mellitus
Open Access
- 1 January 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in ILAR Journal
- Vol. 45 (3) , 231-236
- https://doi.org/10.1093/ilar.45.3.231
Abstract
Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.Keywords
This publication has 42 references indexed in Scilit:
- CD3-specific antibody-induced active tolerance: from bench to bedsideNature Reviews Immunology, 2003
- RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null MiceCirculation, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- The cost of diabetes and diabetes careDiabetes Research and Clinical Practice, 2001
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.Proceedings of the National Academy of Sciences, 1994
- Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.Proceedings of the National Academy of Sciences, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Lipid advanced glycosylation: pathway for lipid oxidation in vivo.Proceedings of the National Academy of Sciences, 1993
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.Journal of Clinical Investigation, 1991